| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/11/1989 | US4847082 Method of treatment of Alzheimer's disease using phytic acid |
| 07/11/1989 | US4847079 Biologically stable interferon compositions comprising thimerosal |
| 07/11/1989 | US4846782 Treatment of cancer with interferon and radiotherapy |
| 07/11/1989 | CA1257254A1 Process for preparing primycin-salts |
| 07/11/1989 | CA1257211A1 Process for obtaining a fviii/vwf complex having therapeutic effects and product thus prepared |
| 07/11/1989 | CA1257210A1 Monoclonal antibody for human hematopoietic glycoproteins and method |
| 07/11/1989 | CA1257199A1 Preparation containing bioactive macromolecular substance for multi-months release in vivo |
| 07/11/1989 | CA1257131A1 Total parenteral and enteral nutrition composition |
| 07/06/1989 | DE3744009A1 Pharmaceutical composition with a neutral flavour and containing one or more amino acids |
| 07/05/1989 | EP0323424A2 Peptide corresponding to HIV-env 583-599, and analogs thereof and applications of the peptides |
| 07/05/1989 | EP0323157A2 Antiviral compounds and methods |
| 07/05/1989 | EP0323149A2 Vectors and compounds for expression of zymogen forms of human protein C |
| 07/05/1989 | EP0322990A1 Polypeptides and derivatives thereof as well as their use in pharmaceutical and diagnostic compositions |
| 07/05/1989 | EP0322870A2 Synthetic plasmid, transformant, feline interferon gene and method for producing feline interferon |
| 07/05/1989 | EP0322786A2 Extraction of process chemicals from labile biological mixtures with halogenated hydrocarbons |
| 07/05/1989 | EP0322779A2 Benzolactam compounds and pharmaceutical uses thereof |
| 07/05/1989 | EP0322667A1 Method for building a wall, construction element and connection slab for applying the method, and wall built by the method |
| 07/05/1989 | EP0322643A1 Medicines containing as a mixture interferon and 1-desoxy-piperidinoses, process for their manufacture and their use |
| 07/05/1989 | CN1033568A Pharmacentical composition containing calcitonins and process for preparing same |
| 07/04/1989 | US4845196 Immonoregulators, antiviral, antitumor |
| 07/04/1989 | US4845195 Herpes virus |
| 07/04/1989 | US4845080 Human calcitonin peptide with salmon calcitonin-like characteristics |
| 07/04/1989 | US4845079 Peptidylaminodiols |
| 07/04/1989 | US4845078 Method for treating hematopoietic diseases |
| 07/04/1989 | US4845077 Method of inducing ovulation |
| 07/04/1989 | US4845076 Antiinflammatory agent |
| 07/04/1989 | US4845075 Biologically active B-chain homodimers |
| 07/04/1989 | US4845032 Dissolving in guanidine hydrochloride, precipitation, chromatography |
| 07/04/1989 | US4845026 Medical diagnosis and monitoring |
| 07/04/1989 | US4844897 Anti-tumor protease preparations |
| 07/04/1989 | US4844895 Composition containing a peptide fragment of platelet factor four and method for restoring suppressed immune responses |
| 07/04/1989 | CA1256814A1 Method for producing interferons |
| 07/04/1989 | CA1256796A1 Cytotoxic conjugates which can be used in therapy and process for their preparation |
| 06/29/1989 | WO1989005979A1 Method and system for detection and treatment of premenstrual syndrome |
| 06/29/1989 | WO1989005857A1 A METHOD OF SIMULTANEOUSLY PRODUCING A LARGE NUMBER OF Leu17-VIP-ANALOGS AND NEW Leu17-VIP-ANALOGS |
| 06/29/1989 | WO1989005852A1 Ribozymes |
| 06/29/1989 | WO1989005850A1 Cloned dna for synthesizing unique glucocerebrosidase |
| 06/29/1989 | WO1989005824A1 Site-specific homogeneous modification of polypeptides to facilitate covalent linkages to a hydrophilic moiety |
| 06/29/1989 | WO1989005822A1 Peptide analogues of insulin-like growth factor 1 (igf-1) or factor 2 (igf-2) |
| 06/29/1989 | WO1989005819A1 Novel hydroxamic acid derivative |
| 06/29/1989 | WO1989005818A1 Purine derivatives having pharmacological action |
| 06/29/1989 | WO1989005816A1 Cellular toxic conjugates |
| 06/29/1989 | WO1989005656A1 Wound healing |
| 06/29/1989 | WO1989005654A1 Linear analogs of atrial natriuretic peptides |
| 06/29/1989 | WO1989005653A1 Topical wound-healing preparations comprising interleukin-1 proteins |
| 06/29/1989 | WO1989005652A1 Pure factor ix product |
| 06/29/1989 | WO1989005650A2 Chemical process |
| 06/29/1989 | WO1989005633A1 Anti-viral therapeutic composition |
| 06/29/1989 | WO1989005631A1 Compositions possessing immunostimulating properties and their applications in human and veterinary medecine |
| 06/29/1989 | DE3743094A1 Retrovirus from the HIV group, method for its replication/isolation and its use |
| 06/28/1989 | EP0322402A2 Method and agents for measuring protein aging |
| 06/28/1989 | EP0322262A1 Basic protein phospholipase A2 of an Elapide snake venom, amino acid sequence thereof, derivatives and fragments thereof, process for obtaining them, therapeutic compositions and diagnostic agents containing them |
| 06/28/1989 | EP0322254A2 Monoclonal antibody capable of suppressing T lymphocyte proliferation |
| 06/28/1989 | EP0322249A2 Collagen products, processes for the preparation thereof and pharmaceutical compositions containing the same |
| 06/28/1989 | EP0322226A2 Site-directed mutagenesis modified glycoprotein hormones and methods of use |
| 06/28/1989 | EP0322206A2 Compositions and methods for improving cold tolerance in animals and humans |
| 06/28/1989 | EP0322184A2 N-(2-Alkyl-3-mercapto-1,5-di-oxoalkyl)glycinamide derivatives and their use as collagenase inhibitors |
| 06/28/1989 | EP0322094A1 N-terminal fragments of human serum albumin |
| 06/28/1989 | EP0321940A2 An improved method for the preparation of natural human growth hormone in pure form |
| 06/28/1989 | EP0321842A1 Soluble recombinant Fc-Epsilon-receptor, the preparation and the use thereof |
| 06/28/1989 | EP0321835A2 Gel filteration of factor VIII |
| 06/28/1989 | EP0321696A2 Novel hydrogenated derivatives of antibiotic A/16686 |
| 06/28/1989 | EP0321606A1 Cellular amphipatic proteins in aggregated forms, and procedure for the production and purification of these proteins |
| 06/28/1989 | EP0321603A1 Process for preparing a whey protein hydrolyzate and a hypoallergenic foodstuff |
| 06/28/1989 | EP0321526A1 Cloning and expression of human tissue factor |
| 06/28/1989 | EP0321497A1 Renin inhibitory peptides having novel c-terminal moieties |
| 06/27/1989 | US4843064 Veterinary animal growth regulator; polypeptides |
| 06/27/1989 | US4843063 Osteoporosis |
| 06/27/1989 | US4843019 Monoclonal antibodies |
| 06/27/1989 | US4843004 Method for the production of human T-T cell hybrids and production suppressor factor by human T-T cell hybrids |
| 06/27/1989 | CA1256370A1 Toxoids of elastase of pseudomonas aeruginosa origin |
| 06/21/1989 | EP0321277A2 An injectable composition for inductive bone repair |
| 06/21/1989 | EP0321221A2 Method for preventing or treating anxiety employing an ace inhibitor |
| 06/21/1989 | EP0321201A2 Ribozymes |
| 06/21/1989 | EP0321128A1 Fatty acid compositions |
| 06/21/1989 | EP0321094A2 Treatment of factor VIII inhibitors |
| 06/21/1989 | EP0320967A2 ANF derivatives with novel bridging |
| 06/21/1989 | EP0320840A2 Peptides, method for their preparation, antibodies to it, and their use in blocking the PAI-1 activity of human blood |
| 06/21/1989 | EP0320785A2 Peptides influencing the activity of the hypophysis of mammalians |
| 06/21/1989 | EP0320528A1 Use of hemocyanins and arylphorins for influencing the immune system and the treatment of tumors |
| 06/21/1989 | EP0320507A1 Scaled-up production of liposome-encapsulated hemoglobin. |
| 06/20/1989 | US4840935 Peptide amino-alcohol derivatives containing a tetrasubstituted carbon atom, inhibiting renin and acid proteases, process for obtention and therapeutical use |
| 06/20/1989 | US4840897 Des(b30)insulin bonded to removable amino acid or di- or tripeptide group |
| 06/20/1989 | US4840896 Human fertility hormones rna encoding by vectors |
| 06/20/1989 | US4840793 Method of reducing tissue damage at an inflammatory site using a monoclonal antibody |
| 06/20/1989 | US4840785 Polypeptide |
| 06/20/1989 | US4840772 Antiglaucoma compositions and methods |
| 06/20/1989 | CA1256027A1 Fibrinophilic urokinase complex and method for production thereof |
| 06/20/1989 | CA1256026A1 Gamma interferon--interleukin-2 synergism |
| 06/15/1989 | WO1989005353A1 Common acute lymphoblastic leukemia antigen |
| 06/15/1989 | WO1989005352A1 DNA ENCODING IgE RECEPTOR alpha-SUBUNIT OR FRAGMENT THEREOF |
| 06/15/1989 | WO1989005349A1 Method of combating viral infections |
| 06/15/1989 | WO1989005347A1 Method to solubilize tissue plasminogen activator |
| 06/15/1989 | WO1989005345A1 Genetic modification of endothelial cells |
| 06/15/1989 | WO1989005343A1 Process for producing syngeneic cells, and their use |
| 06/15/1989 | WO1989005342A1 Process for the production of human factor viii by culturing a human hepatoma cell line |
| 06/15/1989 | WO1989005309A1 Method and means for selection of anti-idiotype antibodies and their use for the diagnosis, monitoring, treatment and/or prevention of cancer, autoimmune or infectious disease |
| 06/15/1989 | WO1989005307A1 Sf-25 colon adenocarcinoma antigen, and antibodies which recognize this antigen |
| 06/15/1989 | WO1989005306A1 Method and compositions relating to regression-associated antigens |
| 06/15/1989 | WO1989005158A1 Low ph pharmaceutical compositions of recombinant beta-interferon |